IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), a
provider of innovative medical advancements and care specializing
in regenerative rehabilitation orthopedic treatments without the
use of surgery or opioids, today announces the addition of Maurice
“Mo” Evans, Michael Pruitt, and Cary Sucoff as independent
directors to IMAC’s board of directors (the “Board”).
“The three new additions to the Board will help
bring additional guidance, direction, and leadership for IMAC
during our continued growth phase,” commented IMAC’s Chief
Executive Officer, Jeffrey Ervin. “Maurice has successfully bridged
his basketball career with outstanding business acumen and
leadership, and we expect his unique perspective will be
instrumental for our branding and brand ambassador program. Michael
has been successful in both the finance and hospitality industries,
so his experience in successfully growing a consumer-focused
business will be beneficial to the Company. Cary’s deep financial
advisory experience and expertise in financing numerous healthcare
and biotech companies will truly be valuable for IMAC.”
Mr. Evans brings a unique blend of sports and
business experience to the Board. During his 11-year professional
basketball tenure, he played in 562 NBA games, won a FIBA
Championship, earned MVP, and was a two-time All-Star and nine-time
playoff participant. He often represented his teams and
organizations in the community with outreach to both youth and
corporate sponsors. From 2010 to 2013, Mr. Evans served as
Executive Vice President for the National Basketball Players
Association and was influential in the 2011 NBA collective
bargaining agreement negotiations.
Over the past 15 years, Mr. Evans has been
active as an investor and advisor for several companies and
charitable organizations. He is Founder and Chief Executive Officer
of E.L.O.S. Sports Group, a global talent agency that provides
branding and management services to professional athletes and
corporations focused on sports business services. Past clients
include NBA MVP James Harden, the late NBA icon Kobe Bryant, SPD
Bank, Delta Airlines, and the Chinese Olympic boxing team. Mr.
Evans received a B.A. from the University of Texas at Austin.
Mr. Pruitt founded Avenel Financial Group, a
boutique merchant banking firm concentrating on value-oriented
investments, both public and private, on behalf of 40 families in
1999. In 2001, he formed Avenel Ventures, a technology investment
and private venture capital firm. In February 2005, Mr. Pruitt
formed Chanticleer Holdings, Inc., then a public holding company
(now known as Sonnet BioTherapeutics Holdings, Inc.), and he served
as Chairman of the Board of Directors and Chief Executive Officer
until April 1, 2020, at which time, the restaurant operations of
Chanticleer Holdings were spun out into a new public entity,
Amergent Hospitality Group, Inc., where Mr. Pruitt has served as
its Chairman and Chief Executive Officer to date. Mr. Pruitt also
served as a director on the board of Hooters of America, LLC from
2011 to 2019. He was an early investor/board member in Appalachian
Mountain Brewery, which was sold to Craft Brew Alliance in 2018.
Mr. Pruitt received a B.A. from Coastal Carolina University in
Conway, South Carolina, where he played on the 1982 and 1983
College World Series Baseball teams. He currently sits on the Board
of Visitors of the E. Craig Wall Sr. College of Business
Administration, the Coastal Education Foundation Board, and the
Athletic Committee of the Board of Trustees at Coastal Carolina
University.
Mr. Sucoff, a former New York prosecutor and law
school professor, has more than 30 years of securities industry
experience encompassing supervisory, banking, and sales
responsibilities. He has participated in the financing of more than
100 public and private healthcare companies and, since 2011, has
owned and operated Equity Source Partners LLC, an advisory and
consulting firm. Mr. Sucoff currently serves on the board of
directors of ContraFect Corporation Legacy Education Alliance,
Inc., First Wave Technologies, Inc., and Galimedix Therapeutics. He
also serves as an advisor to Sapience Therapeutics and LB
Pharmaceuticals.
Mr. Sucoff is the past President of New England
Law/Boston, has been a member of its Board of Trustees for over 25
years, and is the longtime Chairman of its Endowment Committee. Mr.
Sucoff received a B.A. from the State University of New York at
Binghamton in 1974 and a J.D. from New England School of Law in
1977, where he was managing editor of the Law Review and graduated
magna cum laude. He has been a member of the Bar of the State of
New York since 1978.
Jeffrey Ervin continued, “I would also like to
acknowledge the service and assistance that our former board
members – David Ellwanger, George Hampton, and Gerard Hayden –
brought to the Company under their tenure and thank them for their
dedication and effort, especially during the COVID pandemic.”
About IMAC Holdings, Inc.
IMAC Holdings was created in March 2015 to
expand on the footprint of the original IMAC Regeneration Center,
which opened in Kentucky in August 2000. IMAC Regeneration Centers
combine life science advancements with traditional medical care for
movement restricting diseases and conditions. IMAC owns or manages
15 outpatient clinics that provide regenerative, orthopedic and
minimally invasive procedures and therapies. It has partnered with
several active and former professional athletes, opening six Ozzie
Smith IMAC Regeneration Centers, two David Price IMAC Regeneration
Centers, as well as Mike Ditka IMAC Regeneration Centers and a Tony
Delk IMAC Regeneration Center. IMAC’s outpatient medical clinics
emphasize its focus around treating sports and orthopedic injuries
and movement-restricting diseases without surgery or opioids. More
information about IMAC Holdings, Inc. is available at
www.imacregeneration.com.
# # #
Safe Harbor Statement
This press release contains forward-looking
statements. These forward-looking statements, and terms such as
“anticipate,” “expect,” “believe,” “may,” “will,” “should” or other
comparable terms, are based largely on IMAC's expectations and are
subject to a number of risks and uncertainties, certain of which
are beyond IMAC's control. Actual results could differ materially
from these forward-looking statements as a result of, among other
factors, risks and uncertainties associated with its ability to
raise additional funding, its ability to maintain and grow its
business, variability of operating results, its ability to maintain
and enhance its brand, its development and introduction of new
products and services, the successful integration of acquired
companies, technologies and assets, marketing and other business
development initiatives, competition in the industry, general
government regulation, economic conditions, dependence on key
personnel, the ability to attract, hire and retain personnel who
possess the skills and experience necessary to meet customers’
requirements, and its ability to protect its intellectual property.
IMAC encourages you to review other factors that may affect its
future results in its registration statement and in its other
filings with the Securities and Exchange Commission. In light of
these risks and uncertainties, there can be no assurance that the
forward-looking information contained in this press release will in
fact occur.
IMAC Press Contact:
Laura Fristoe
lfristoe@imacrc.com
Investor Relations:
Bret Shapiro
(516) 222-2560
brets@coreir.com
IMAC (NASDAQ:IMAC)
Historical Stock Chart
From Mar 2024 to Apr 2024
IMAC (NASDAQ:IMAC)
Historical Stock Chart
From Apr 2023 to Apr 2024